drugset / Trial / NCT05149651
Efficacy of Totalfill® and ProRoot MTA® as Pulpotomy Agent in Primary Molars
RandomizedParallel-groupDouble-blindTreatment
Summary
An experimental prospective double-blind, randomized clinical trial (RCT) with parallel design. To evaluate the outcome of using 2 pulpotomy agents: Totalfill® as study group and mineral trioxide aggregate (MTA®) as a control.
Timeline
- Start
- 2017-01-01
- Primary completion
- 2018-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ProRoot White MTA® | Unknown | — | — |
| Subject | bioceramic sealer | Unknown | — | — |